4

OWNERSHIP DOCUMENT

Company: Aldeyra Therapeutics, Inc.
Filed: May 26, 2016
Period of Report: May 26, 2016
Accession Number: 0001019056-16-001354

View Document ↗ View on SEC.gov ↗